Disinhibition, an emerging pharmacology of learning and memory
MetadataShow full item record
CitationMöhler, Hanns, and Uwe Rudolph. 2017. “Disinhibition, an emerging pharmacology of learning and memory.” F1000Research 6 (1): F1000 Faculty Rev-101. doi:10.12688/f1000research.9947.1. http://dx.doi.org/10.12688/f1000research.9947.1.
AbstractLearning and memory are dependent on interactive excitatory and inhibitory mechanisms. In this review, we discuss a mechanism called disinhibition, which is the release of an inhibitory constraint that effectively results in an increased activity in the target neurons (for example, principal or projection neurons). We focus on discussing the role of disinhibition in learning and memory at a basic level and in disease models with cognitive deficits and highlight a strategy to reverse cognitive deficits caused by excess inhibition, through disinhibition of α5-containing GABA A receptors mediating tonic inhibition in the hippocampus, based on subtype-selective negative allosteric modulators as a novel class of drugs.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:31731798
- HMS Scholarly Articles